Metropolis Healthcare, 542650, METROPOLIS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

10,335.59
69.49
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

10,300.77
N/A
7.72

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.77
5.93
5.05

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.52
1.25
1.15

PAT CAGR (%)

10 Years
5 Years
3 Years

7.01
-4.56
0.48

P:E (Median)

8 Years
5 Years
3 Years

-
61.60
60.77

P:BV (Average)

8 Years
5 Years
3 Years

-
11.05
7.90

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
31.64
28.24

Earnings Forecasts:

(Updated: 27-09-2025)

Description 2024 2025 2026 2027
Adj EPS 28.29 38.17 48.06 57.69
P/E Ratio 70.57 52.30 41.54 34.60
Revenue 1331.2 1640.32 1855.51 2074.52
EBITDA 303 391.04 461.74 520.41
Net Income 144.97 201.05 252.37 279.84
ROA 8.47 9.92 11.49 12.35
P/B Ratio 7.77 7.01 6.19 5.55
ROE 11.95 14.24 15.99 17.03
FCFF 202.36 196.3 292.16 357.79
FCFF Yield
Net Debt 85.87 -176.62 -362.98 -583.5
BVPS 256.94 284.61 322.67 359.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 323.63 286.14 13.10% 311.95 292.27 6.73% 296.88 269.41 10.20% 321.57 285.46 12.65%
Expenses 246.57 217.87 13.17% 259.21 218.34 18.72% 231.78 210.58 10.07% 239.55 217.98 9.90%
EBITDA 77.06 68.27 12.88% 52.74 73.92 -28.65% 65.10 58.83 10.66% 82.02 67.47 21.57%
EBIDTM 23.81% 23.86% 16.91% 25.29% 21.93% 21.83% 25.51% 23.64%
Other Income 2.78 2.83 -1.77% 7.60 2.02 276.24% 3.03 5.19 -41.62% 3.59 2.01 78.61%
Interest 4.29 4.61 -6.94% 4.43 5.65 -21.59% 4.49 5.24 -14.31% 4.73 5.62 -15.84%
Depreciation 27.86 24.76 12.52% 27.28 25.24 8.08% 26.85 24.14 11.23% 26.01 21.37 21.71%
PBT 47.68 41.72 14.29% 28.63 45.05 -36.45% 36.80 34.63 6.27% 54.87 42.49 29.14%
Tax 12.10 10.44 15.90% 4.78 13.27 -63.98% 9.40 7.93 18.54% 12.60 11.21 12.40%
PAT 35.58 31.28 13.75% 23.85 31.78 -24.95% 27.41 26.70 2.66% 42.26 31.28 35.10%
PATM 11.00% 10.93% 7.65% 10.87% 9.23% 9.91% 13.14% 10.96%
EPS 6.87 6.04 13.74% 4.60 6.14 -25.08% 5.29 5.15 2.72% 8.16 6.04 35.10%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 386.06 313.36 23.20% 345.29 331.00 4.32% 322.77 291.12 10.87% 349.79 308.50 13.38%
Expenses 296.31 234.54 26.34% 283.00 251.02 12.74% 250.76 226.27 10.82% 259.91 233.69 11.22%
EBITDA 89.76 78.81 13.89% 62.30 79.98 -22.11% 72.01 64.85 11.04% 89.88 74.81 20.14%
EBIDTM 23.25% 25.15% 18.04% 24.16% 22.31% 22.28% 25.69% 24.25%
Other Income 7.52 2.46 205.69% 6.97 2.54 174.41% 2.56 2.31 10.82% 3.13 1.22 156.56%
Interest 5.20 4.65 11.83% 4.60 5.57 -17.41% 4.53 5.31 -14.69% 4.79 5.68 -15.67%
Depreciation 30.84 25.54 20.75% 28.63 26.42 8.36% 27.70 24.99 10.84% 26.82 22.24 20.59%
PBT 61.23 51.08 19.87% 36.04 50.53 -28.68% 42.34 36.86 14.87% 61.40 48.11 27.62%
Tax 15.98 12.97 23.21% 6.81 14.01 -51.39% 10.86 9.57 13.48% 14.70 12.45 18.07%
PAT 45.25 38.11 18.74% 29.23 36.52 -19.96% 31.47 27.29 15.32% 46.70 35.66 30.96%
PATM 11.72% 12.16% 8.47% 11.03% 9.75% 9.37% 13.35% 11.56%
EPS 8.70 7.41 17.41% 5.63 7.11 -20.82% 6.12 5.30 15.47% 9.08 6.92 31.21%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,254.03 1,216.54 1,103.43 1,066.04 1,157.01 961.39 665.31 581.21 484.95 355.95 304.40 Net Sales Growth 10.65% 10.25% 3.51% -7.86% 20.35% 44.50% 14.47% 19.85% 36.24% 16.93% Cost Of Goods Sold 247.67 244.49 220.48 235.55 261.60 244.23 167.25 139.08 111.64 91.41 82.62 Gross Profit 1,006.36 972.05 882.95 830.49 895.41 717.15 498.06 442.13 373.32 264.54 221.78 GP Margin 80.25% 79.90% 80.02% 77.90% 77.39% 74.60% 74.86% 76.07% 76.98% 74.32% 72.86% Total Expenditure 977.11 944.27 840.03 794.56 832.71 676.52 489.25 433.74 348.47 246.99 216.08 Power & Fuel Cost - 17.81 15.04 13.50 12.84 11.52 9.16 7.44 6.76 5.58 4.81 % Of Sales - 1.46% 1.36% 1.27% 1.11% 1.20% 1.38% 1.28% 1.39% 1.57% 1.58% Employee Cost - 271.98 246.60 228.16 218.24 188.24 147.67 136.95 109.72 84.16 70.04 % Of Sales - 22.36% 22.35% 21.40% 18.86% 19.58% 22.20% 23.56% 22.63% 23.64% 23.01% Manufacturing Exp. - 48.38 40.72 29.57 31.36 25.63 19.66 15.15 14.30 5.97 6.95 % Of Sales - 3.98% 3.69% 2.77% 2.71% 2.67% 2.96% 2.61% 2.95% 1.68% 2.28% General & Admin Exp. - 346.79 293.45 277.09 301.99 176.66 125.45 126.65 97.10 56.60 48.02 % Of Sales - 28.51% 26.59% 25.99% 26.10% 18.38% 18.86% 21.79% 20.02% 15.90% 15.78% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 14.82 23.75 10.70 6.68 30.23 20.07 8.48 8.96 3.27 0.00 % Of Sales - 1.22% 2.15% 1.00% 0.58% 3.14% 3.02% 1.46% 1.85% 0.92% 1.19% EBITDA 276.92 272.27 263.40 271.48 324.30 284.87 176.06 147.47 136.48 108.96 88.32 EBITDA Margin 22.08% 22.38% 23.87% 25.47% 28.03% 29.63% 26.46% 25.37% 28.14% 30.61% 29.01% Other Income 17.00 17.63 12.00 23.72 16.15 12.31 29.32 20.52 15.63 21.67 41.08 Interest 17.94 22.99 27.25 31.29 24.54 11.26 10.01 3.37 2.88 1.36 1.26 Depreciation 108.00 104.89 90.73 84.96 60.26 43.78 30.85 15.44 13.97 10.84 10.39 PBT 167.98 162.02 157.41 178.95 255.65 242.13 164.52 149.19 135.26 118.44 117.75 Tax 38.88 37.23 41.52 40.00 72.01 59.48 27.94 47.73 39.51 39.15 32.24 Tax Rate 23.15% 22.98% 26.38% 22.35% 26.52% 24.57% 19.96% 31.99% 29.21% 33.05% 29.30% PAT 129.10 124.80 115.89 138.95 199.53 182.65 112.05 101.46 95.76 79.29 77.80 PAT before Minority Interest 129.10 124.80 115.89 138.95 199.53 182.65 112.05 101.46 95.76 79.29 77.80 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.29% 10.26% 10.50% 13.03% 17.25% 19.00% 16.84% 17.46% 19.75% 22.28% 25.56% PAT Growth 6.66% 7.69% -16.60% -30.36% 9.24% 63.01% 10.44% 5.95% 20.77% 1.92% EPS 24.92 24.09 22.37 26.82 38.52 35.26 21.63 19.59 18.49 15.31 15.02

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,403.91 1,331.20 1,207.71 1,148.21 1,228.34 997.99 856.41 761.18 647.16 544.72 524.02 Net Sales Growth 12.86% 10.23% 5.18% -6.52% 23.08% 16.53% 12.51% 17.62% 18.81% 3.95% Cost Of Goods Sold 284.58 268.68 242.57 253.26 276.02 252.16 204.13 173.51 145.90 135.10 143.33 Gross Profit 1,119.33 1,062.52 965.14 894.95 952.31 745.82 652.27 587.67 501.27 409.62 380.69 GP Margin 79.73% 79.82% 79.91% 77.94% 77.53% 74.73% 76.16% 77.21% 77.46% 75.20% 72.65% Total Expenditure 1,089.98 1,022.90 919.78 857.10 882.67 708.20 619.27 557.23 468.69 391.23 387.93 Power & Fuel Cost - 19.24 16.20 14.43 14.73 12.00 12.49 11.00 9.99 9.12 9.03 % Of Sales - 1.45% 1.34% 1.26% 1.20% 1.20% 1.46% 1.45% 1.54% 1.67% 1.72% Employee Cost - 313.75 275.78 252.73 233.17 198.64 190.16 176.21 147.37 127.69 115.71 % Of Sales - 23.57% 22.83% 22.01% 18.98% 19.90% 22.20% 23.15% 22.77% 23.44% 22.08% Manufacturing Exp. - 50.08 46.05 31.30 48.35 34.23 22.51 19.24 18.84 10.86 8.93 % Of Sales - 3.76% 3.81% 2.73% 3.94% 3.43% 2.63% 2.53% 2.91% 1.99% 1.70% General & Admin Exp. - 353.15 307.81 289.77 300.57 177.98 167.62 166.23 132.17 101.87 101.19 % Of Sales - 26.53% 25.49% 25.24% 24.47% 17.83% 19.57% 21.84% 20.42% 18.70% 19.31% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 17.99 31.37 15.60 9.83 33.19 22.37 11.03 14.43 6.59 0.00 % Of Sales - 1.35% 2.60% 1.36% 0.80% 3.33% 2.61% 1.45% 2.23% 1.21% 1.86% EBITDA 313.95 308.30 287.93 291.11 345.67 289.79 237.14 203.95 178.47 153.49 136.09 EBITDA Margin 22.36% 23.16% 23.84% 25.35% 28.14% 29.04% 27.69% 26.79% 27.58% 28.18% 25.97% Other Income 20.18 15.11 9.12 17.46 20.03 12.05 8.57 8.21 7.77 25.59 21.80 Interest 19.12 23.89 27.89 31.85 25.02 11.56 12.65 4.12 3.54 1.94 1.62 Depreciation 113.99 108.68 94.47 89.22 63.22 45.94 39.27 20.07 19.02 17.23 20.54 PBT 201.01 190.85 174.69 187.50 277.45 244.32 193.78 187.98 163.68 159.92 135.73 Tax 48.35 45.34 46.23 44.11 78.67 60.97 41.18 62.94 51.84 52.66 46.09 Tax Rate 24.05% 23.76% 26.46% 23.53% 26.82% 24.95% 24.33% 33.48% 31.67% 32.93% 36.00% PAT 152.65 144.96 127.82 142.88 214.19 183.10 127.84 121.58 104.23 107.26 73.62 PAT before Minority Interest 152.08 145.51 128.46 143.39 214.69 183.35 128.07 125.04 111.84 107.26 81.93 Minority Interest -0.57 -0.55 -0.64 -0.51 -0.50 -0.25 -0.23 -3.46 -7.61 0.00 -8.31 PAT Margin 10.87% 10.89% 10.58% 12.44% 17.44% 18.35% 14.93% 15.97% 16.11% 19.69% 14.05% PAT Growth 10.95% 13.41% -10.54% -33.29% 16.98% 43.23% 5.15% 16.65% -2.82% 45.69% EPS 29.47 27.98 24.68 27.58 41.35 35.35 24.68 23.47 20.12 20.71 14.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,244.45 1,031.19 936.02 839.21 664.81 512.38 415.40 364.03 266.75 220.05 Share Capital 10.36 10.25 10.24 10.23 10.22 10.13 10.04 9.54 9.54 9.54 Total Reserves 1,226.16 1,013.21 918.43 817.18 646.06 500.19 402.78 352.78 257.16 210.51 Non-Current Liabilities 405.09 226.35 417.26 491.93 113.78 166.30 141.21 78.43 20.40 -0.86 Secured Loans 0.00 0.00 28.61 158.68 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 2.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 232.79 34.72 185.06 170.93 43.68 133.39 133.13 70.75 2.54 2.41 Current Liabilities 435.62 263.13 290.50 347.89 222.04 153.67 183.12 164.35 232.81 71.49 Trade Payables 107.06 93.40 85.72 94.23 95.49 70.90 36.05 26.52 21.08 18.52 Other Current Liabilities 111.67 115.14 98.73 80.61 71.67 57.36 39.25 31.66 92.86 28.19 Short Term Borrowings 0.00 0.00 51.52 99.87 0.00 0.00 17.34 0.00 0.00 0.00 Short Term Provisions 216.89 54.59 54.53 73.18 54.88 25.41 90.47 106.18 118.88 24.78 Total Liabilities 2,085.16 1,520.67 1,643.78 1,679.03 1,000.63 832.35 739.73 606.81 519.96 290.68 Net Block 1,129.11 1,120.09 1,065.77 1,004.73 307.09 215.78 162.90 157.02 141.73 82.34 Gross Block 1,521.89 1,421.99 1,276.94 1,160.40 392.59 265.23 204.38 185.53 152.56 158.32 Accumulated Depreciation 392.78 301.90 211.17 155.66 85.50 49.45 41.47 28.51 10.83 75.99 Non Current Assets 1,638.50 1,219.47 1,341.11 1,264.88 379.56 510.27 453.38 288.15 208.72 133.81 Capital Work in Progress 0.00 0.00 19.51 5.78 0.00 2.99 5.77 0.00 0.00 0.00 Non Current Investment 255.55 36.65 36.65 36.65 3.54 129.78 131.73 30.50 39.12 39.12 Long Term Loans & Adv. 253.26 59.86 217.97 201.44 67.29 150.06 141.90 73.48 11.65 12.35 Other Non Current Assets 0.59 2.87 1.21 16.28 1.64 11.67 11.08 27.15 16.22 0.00 Current Assets 446.66 301.20 302.67 414.15 621.06 322.08 286.36 318.67 311.24 156.88 Current Investments 65.60 53.07 13.06 13.75 8.33 0.00 3.36 67.52 99.86 63.45 Inventories 31.55 33.89 41.27 47.01 38.12 17.46 19.65 14.96 9.01 9.51 Sundry Debtors 113.66 130.03 126.19 140.47 130.50 124.40 118.27 81.81 63.18 46.69 Cash & Bank 25.52 30.46 42.94 115.36 380.62 132.01 25.80 29.62 5.72 13.71 Other Current Assets 210.32 5.88 8.00 12.53 63.50 48.21 119.28 124.77 133.47 23.53 Short Term Loans & Adv. 204.30 47.85 71.20 85.03 57.79 45.05 107.52 120.55 130.65 21.21 Net Current Assets 11.04 38.07 12.17 66.26 399.03 168.41 103.24 154.31 78.43 85.39 Total Assets 2,085.16 1,520.67 1,643.78 1,679.03 1,000.62 832.35 739.74 606.82 519.96 290.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,330.97 1,096.16 988.23 886.20 706.60 523.50 418.54 414.77 323.17 265.00 Share Capital 10.36 10.25 10.24 10.23 10.22 10.13 10.04 9.54 9.54 9.54 Total Reserves 1,312.69 1,078.18 970.64 864.17 687.85 511.30 405.91 403.52 313.58 255.45 Non-Current Liabilities 443.80 373.45 416.66 492.88 110.93 194.63 141.74 147.66 15.72 1.06 Secured Loans 5.27 0.00 28.61 158.68 0.00 0.00 0.04 0.20 0.36 0.46 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.78 Long Term Provisions 240.38 186.97 190.65 173.80 43.70 156.34 140.38 145.88 3.15 3.01 Current Liabilities 487.91 275.48 302.83 363.85 240.17 210.20 241.37 232.97 151.85 105.02 Trade Payables 125.86 99.44 94.08 103.21 110.56 85.03 42.85 35.34 35.91 38.13 Other Current Liabilities 140.24 119.68 101.52 84.26 73.22 74.11 49.87 42.42 102.44 38.25 Short Term Borrowings 0.00 0.00 50.44 99.87 0.00 0.00 17.58 0.37 0.40 0.19 Short Term Provisions 221.82 56.35 56.80 76.52 56.40 51.05 131.07 154.84 13.11 28.44 Total Liabilities 2,266.35 1,748.21 1,710.20 1,744.90 1,059.16 929.99 803.08 809.77 511.72 391.34 Net Block 1,446.96 1,177.06 1,120.67 1,058.93 343.11 296.37 212.81 207.44 202.35 147.67 Gross Block 1,876.92 1,493.43 1,344.29 1,223.49 438.35 366.11 271.30 246.45 219.74 272.76 Accumulated Depreciation 429.96 316.37 223.63 164.56 95.24 69.74 58.49 39.01 17.38 125.08 Non Current Assets 1,726.83 1,402.77 1,369.61 1,289.47 414.50 492.20 381.48 367.09 226.61 165.87 Capital Work in Progress 0.00 0.00 19.51 5.78 0.00 2.99 5.77 0.00 0.95 0.56 Non Current Investment 1.75 1.75 1.75 1.75 1.75 1.75 2.27 1.76 7.79 1.76 Long Term Loans & Adv. 271.71 218.73 226.36 206.61 67.91 179.09 150.19 149.29 13.09 15.84 Other Non Current Assets 6.41 5.23 1.32 16.40 1.73 12.00 10.43 8.61 2.43 0.04 Current Assets 539.52 345.43 340.60 455.42 644.68 437.78 421.60 442.67 285.12 225.47 Current Investments 69.24 53.07 13.06 13.75 8.33 12.57 31.02 100.42 134.05 78.68 Inventories 47.84 38.69 44.59 51.11 40.55 24.40 26.10 21.19 14.13 17.62 Sundry Debtors 147.95 126.28 121.89 135.49 122.98 128.25 136.85 100.68 80.29 77.14 Cash & Bank 49.02 71.22 93.19 166.94 419.70 210.47 80.24 60.14 40.51 43.12 Other Current Assets 225.47 7.45 9.39 9.81 53.12 62.10 147.40 160.24 16.14 8.89 Short Term Loans & Adv. 214.51 48.71 58.48 78.33 50.00 57.46 135.02 155.50 12.14 6.29 Net Current Assets 51.61 69.96 37.76 91.57 404.50 227.58 180.24 209.70 133.26 120.45 Total Assets 2,266.35 1,748.20 1,710.21 1,744.89 1,059.18 929.98 803.08 809.76 511.73 391.34

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 275.01 269.01 237.74 244.04 236.23 156.13 56.43 74.48 61.54 57.34 PBT 162.02 157.41 178.95 271.55 242.13 139.99 149.19 135.26 118.44 110.04 Adjustment 126.38 116.52 96.11 54.34 71.33 49.41 3.80 4.78 -8.23 -30.52 Changes in Working Capital 20.39 22.34 6.72 -5.67 -22.16 14.34 -44.83 -18.92 -12.17 3.14 Cash after chg. in Working capital 308.80 296.26 281.78 320.21 291.29 203.74 108.17 121.12 98.04 82.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.77 Tax Paid -33.79 -27.26 -44.04 -76.17 -55.06 -47.61 -51.74 -46.64 -36.49 -26.10 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -196.09 -81.00 46.72 -738.21 59.42 -51.13 -4.35 18.86 -51.14 107.58 Net Fixed Assets -99.90 -125.54 -130.27 -773.59 -124.37 -58.07 -24.62 -32.97 5.76 -8.66 Net Investments -231.43 -40.01 0.69 -38.53 117.91 5.31 -37.07 40.96 -36.41 73.57 Others 135.24 84.55 176.30 73.91 65.88 1.63 57.34 10.87 -20.49 42.67 Cash from Financing Activity -84.50 -183.00 -287.87 171.97 -31.27 -46.37 -63.97 -81.58 -16.55 -154.99 Net Cash Inflow / Outflow -5.58 5.01 -3.40 -322.20 264.38 58.63 -11.89 11.77 -6.14 9.92 Opening Cash & Equivalents 28.59 24.09 27.49 347.68 83.30 8.80 20.69 8.93 10.62 3.36 Closing Cash & Equivalent 22.68 28.59 24.09 27.49 347.68 67.43 8.80 20.69 4.48 13.29

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 262.75 264.07 247.09 253.27 249.03 215.00 90.15 103.93 101.75 PBT 190.85 174.69 187.50 293.35 244.32 168.73 186.55 163.68 159.92 Adjustment 131.58 121.31 104.06 58.83 76.84 82.72 21.78 20.75 -3.00 Changes in Working Capital -15.71 5.45 7.11 -16.40 -15.31 27.97 -50.78 -22.92 -3.90 Cash after chg. in Working capital 306.72 301.45 298.67 335.79 305.86 279.43 157.55 161.51 153.02 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -43.97 -37.38 -51.58 -82.51 -56.83 -64.43 -67.40 -57.57 -51.27 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -201.06 -89.41 46.79 -737.57 61.70 -104.83 35.34 1.88 -85.78 Net Fixed Assets -99.90 -125.54 -130.27 -773.59 -124.37 -58.07 -24.62 -32.97 Net Investments -231.43 -40.01 0.69 -38.53 117.91 5.31 -37.07 40.96 Others 130.27 76.14 176.37 74.55 68.16 -52.07 97.03 -6.11 Cash from Financing Activity -86.63 -181.20 -292.33 162.52 -32.69 -55.32 -118.15 -87.30 -17.30 Net Cash Inflow / Outflow -24.94 -6.54 1.56 -321.78 278.04 54.85 7.35 18.51 -1.33 Opening Cash & Equivalents 62.62 68.83 65.98 386.59 107.17 51.37 43.47 25.51 26.83 Closing Cash & Equivalent 39.48 62.62 68.83 65.98 386.59 107.17 51.37 43.47 25.51

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 238.71 199.79 181.34 161.69 128.39 100.79 82.27 379.65 279.45 230.57 ROA 6.92% 7.32% 8.36% 14.89% 19.93% 14.26% 15.07% 17.00% 19.56% 24.02% ROE 11.04% 11.87% 15.82% 26.90% 31.31% 24.28% 26.18% 30.45% 32.58% 29.57% ROCE 16.26% 18.02% 19.87% 33.60% 43.05% 31.74% 38.29% 43.80% 48.85% 41.25% Fixed Asset Turnover 0.83 0.82 0.87 1.49 2.92 2.83 2.98 2.87 2.29 1.98 Receivable days 36.56 42.38 45.65 42.74 48.39 66.57 62.82 54.56 56.33 56.28 Inventory Days 9.82 12.43 15.11 13.43 10.55 10.18 10.87 9.02 9.50 11.50 Payable days 149.63 148.27 139.42 132.35 124.33 51.88 36.19 33.75 36.40 34.96 Cash Conversion Cycle -103.26 -93.46 -78.66 -76.18 -65.39 24.87 37.50 29.83 29.43 32.82 Total Debt/Equity 0.00 0.00 0.09 0.31 0.00 0.00 0.04 0.00 0.00 0.02 Interest Cover 8.05 6.78 6.72 12.07 22.49 14.99 45.34 48.03 88.28 88.60

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 255.41 212.47 191.54 170.88 136.57 102.99 82.89 432.82 338.57 277.67 ROA 7.25% 7.43% 8.30% 15.31% 18.43% 14.78% 15.51% 16.93% 23.75% 19.06% ROE 12.07% 12.42% 15.46% 27.31% 30.07% 27.33% 30.17% 30.38% 36.47% 26.16% ROCE 17.59% 18.73% 19.83% 34.39% 41.60% 37.90% 45.10% 45.22% 54.28% 40.06% Fixed Asset Turnover 0.79 0.85 0.89 1.48 2.48 2.69 2.94 2.78 2.21 1.97 Receivable days 37.60 37.50 40.91 38.40 45.94 56.49 56.95 51.03 52.74 53.38 Inventory Days 11.86 12.59 15.21 13.62 11.88 10.76 11.34 9.96 10.64 12.52 Payable days 153.03 145.60 142.17 141.34 141.56 49.58 35.51 37.97 44.90 44.18 Cash Conversion Cycle -103.57 -95.51 -86.05 -89.32 -83.74 17.67 32.78 23.02 18.48 21.71 Total Debt/Equity 0.01 0.00 0.08 0.30 0.00 0.00 0.04 0.00 0.00 0.03 Interest Cover 8.99 7.26 6.89 12.72 22.13 14.38 46.64 47.17 83.60 80.00

Top Investors:

hdfc mutual fund - hdfc focused fund

uti value fund

franklin india smaller companies fund

kotak small cap fund

nippon life india trustee ltd-a/c nippon india small cap fund

tata business cycle fund

aditya birla sun life trustee private limited a/c aditya birla sun life flexi cap fund

sundaram mutual fund a/c sundaram services fund

canara robeco mutual fund a/c canara robeco small cap fund

icici prudential pharma healthcare and diaganostics (p.h.d) fund

Annual Reports:

News Update:

Metropolis Healthcare acquires Ambika Pathology in Kolhapur
19th Sep 2025, 11:42 AM

Established in 1995, Ambika Pathology Laboratory has built a strong reputation for quality, accuracy, and patient-centric care
Read More
Metropolis Healthcare incorporates wholly owned subsidiary
16th Sep 2025, 15:42 PM

The newly incorporated entity belongs to Healthcare Technology industry
Read More
Metropolis Health. - Quarterly Results
7th Aug 2025, 17:05 PM

Read More

Metropolis Healthcare Ltd.

Healthcare Services - Diagnostic

BSE: 542650 | NSE: METROPOLIS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Metropolis Healthcare Ltd.

Healthcare Services - Diagnostic

BSE: 542650 | NSE: METROPOLIS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: